I2P2 and GHS are two of the major OSHA issues for 2011 that will be impacting health
and safety programs in all industries in the United States, including the biotechnology and pharmaceutical industry. In this episode of the BioPharma EHS podcast, Dean M. Calhoun, CIH, President and CEO of Affygility Solutions provides a brief overview of what we might see in these two programs. To listen in, please click on the player below or subscribe to the podcast via iTunes.
To submit questions or feedback to the podcast, please call our listener voicemail feedback line at 206-984-3214 or contact us at Affygility Solutions.